Published on 24 Sep 2023 on Simply Wall St. via Yahoo Finance
Insiders Give Up US$292k As NGM Biopharmaceuticals Stock Drops To US$1.31
Insiders who acquired US$462k worth of NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) stock at an average price of US$3.56 in the past 12 months may be dismayed by the recent 15% price decline. This is not good as insiders invest based on expectations that their money will appreciate over time. However, as a result of recent losses, their original investment is now worth only US$170k.
Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.
View our latest analysis for NGM Biopharmaceuticals